Compared with the 0.3 μg/animal group, the ratio of tumor-to-muscle in the 100 μg/animal group decreased significantly, indicating that PD-L1 binding was inhibited by an excess of unlabeled NOTA-Nb109. This evidence concerns the gene CD274 and neoplasm.